These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36602940)
21. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677 [TBL] [Abstract][Full Text] [Related]
22. The Contribution of GWAS Loci in Familial Dyslipidemias. Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539 [TBL] [Abstract][Full Text] [Related]
23. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia. Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682 [TBL] [Abstract][Full Text] [Related]
24. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476 [TBL] [Abstract][Full Text] [Related]
25. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia. Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599 [TBL] [Abstract][Full Text] [Related]
26. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590 [TBL] [Abstract][Full Text] [Related]
27. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia? Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432 [TBL] [Abstract][Full Text] [Related]
29. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia. Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425 [TBL] [Abstract][Full Text] [Related]
30. Impact of obesity in primary hyperlipidemias. Carmena R; Ascaso JF; Real JT Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432 [TBL] [Abstract][Full Text] [Related]
31. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276 [TBL] [Abstract][Full Text] [Related]
32. [Hyperlipidemia, blood coagulation factors, hereditary familial factors and coronary atherosclerosis]. Penco M; Del Porto G; Dagianti A Cardiologia; 1991 Dec; 36(12 Suppl 1):15-23. PubMed ID: 1841765 [TBL] [Abstract][Full Text] [Related]
33. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia]. Moulin P Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476 [TBL] [Abstract][Full Text] [Related]
34. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia. Shen GX; Mymin D; Dembinski T; Krahn A; Angel A Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064 [TBL] [Abstract][Full Text] [Related]
35. The diagnosis and management of hyperlipidemia. Gotto AM; Jones PH; Scott LW Dis Mon; 1986 May; 32(5):245-311. PubMed ID: 3519132 [No Abstract] [Full Text] [Related]
36. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia. Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500 [TBL] [Abstract][Full Text] [Related]
37. Combination drug therapy for familial combined hyperlipidemia. East C; Bilheimer DW; Grundy SM Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029 [TBL] [Abstract][Full Text] [Related]
38. Monogenic, polygenic, and oligogenic familial hypercholesterolemia. Tada H; Nohara A; Kawashiri MA Curr Opin Lipidol; 2019 Aug; 30(4):300-306. PubMed ID: 31290811 [TBL] [Abstract][Full Text] [Related]